Zobrazeno 1 - 5
of 5
pro vyhledávání: '"on behalf of the LEOSS study group"'
Autor:
Beate Heissig, Yousef Salama, Roman Iakoubov, Joerg Janne Vehreschild, Ricardo Rios, Tatiane Nogueira, Maria J. G. T. Vehreschild, Melanie Stecher, Hirotake Mori, Julia Lanznaster, Eisuke Adachi, Carolin Jakob, Yoko Tabe, Maria Ruethrich, Stefan Borgmann, Toshio Naito, Kai Wille, Simon Valenti, Martin Hower, Nobutaka Hattori, Siegbert Rieg, Tetsutaro Nagaoka, Bjoern-Erik Jensen, Hiroshi Yotsuyanagi, Bernd Hertenstein, Hideoki Ogawa, Christoph Wyen, Eiki Kominami, Christoph Roemmele, Satoshi Takahashi, Jan Rupp, Kazuhisa Takahashi, Frank Hanses, Koichi Hattori, on behalf of the LEOSS Study Group
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2549 (2022)
Although there is strong evidence that SARS-CoV-2 infection is associated with adverse outcomes in certain ethnic groups, the association of disease severity and risk factors such as comorbidities and biomarkers with racial disparities remains undefi
Externí odkaz:
https://doaj.org/article/34847be6412547e9a351db8920480279
Autor:
Sebastian Cremer, Lisa Pilgram, Alexander Berkowitsch, Melanie Stecher, Siegbert Rieg, Mariana Shumliakivska, Denisa Bojkova, Julian Uwe Gabriel Wagner, Galip Servet Aslan, Christoph Spinner, Guillermo Luxán, Frank Hanses, Sebastian Dolff, Christiane Piepel, Clemens Ruppert, Andreas Guenther, Maria Madeleine Rüthrich, Jörg Janne Vehreschild, Kai Wille, Martina Haselberger, Hanno Heuzeroth, Arne Hansen, Thomas Eschenhagen, Jindrich Cinatl, Sandra Ciesek, Stefanie Dimmeler, Stefan Borgmann, Andreas Zeiher, on behalf of the LEOSS study group
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Aims Patients with cardiovascular comorbidities have a significantly increased risk for a critical course of COVID-19. As the SARS-CoV2 virus enters cells via the angiotensin-converting enzyme receptor II (ACE2), drugs which interact with the renin a
Externí odkaz:
https://doaj.org/article/b5baff8de9bf4e33b669346990756db5
Autor:
Group, Marie Louise de Hesselle, Stefan Borgmann, Siegbert Rieg, Jörg Janne Vehreschild, Sebastian Rasch, Carolin E. M. Koll, Martin Hower, Melanie Stecher, Daniel Ebert, Frank Hanses, Julia Schumann, on behalf of the LEOSS Study Group on behalf of the LEOSS Study
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2469
During the COVID-19 pandemic, large numbers of elderly, multimorbid people required treatment in intensive care units. This study investigated how the inherent patient factors age and comorbidity burden affected the treatment strategy and the outcome
Autor:
de Hesselle ML; University Clinic and Outpatient Clinic for Anesthesiology and Operative Intensive Care, University Medicine Halle (Saale), 06112 Halle (Saale), Germany., Borgmann S; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, 85049 Ingolstadt, Germany., Rieg S; Department of Medicine II, University of Freiburg, 79106 Freiburg, Germany., Vehreschild JJ; Department II of Internal Medicine, Hematology/Oncology, Goethe University Frankfurt, 60323 Frankfurt, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50937 Cologne, Germany., Rasch S; Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University of Munich, 81675 Munich, Germany., Koll CEM; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50937 Cologne, Germany., Hower M; Department of Pneumology, Infectious Diseases, Internal Medicine and Intensive Care, Klinikum Dortmund GmbH, 44137 Dortmund, Germany., Stecher M; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, 50937 Cologne, Germany., Ebert D; University Clinic and Outpatient Clinic for Anesthesiology and Operative Intensive Care, University Medicine Halle (Saale), 06112 Halle (Saale), Germany., Hanses F; Emergency Department and Department for Infection Control and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany., Schumann J; University Clinic and Outpatient Clinic for Anesthesiology and Operative Intensive Care, University Medicine Halle (Saale), 06112 Halle (Saale), Germany., On Behalf Of The Leoss Study Group
Publikováno v:
Journal of clinical medicine [J Clin Med] 2023 Mar 24; Vol. 12 (7). Date of Electronic Publication: 2023 Mar 24.
Autor:
Heissig B; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Salama Y; An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, P.O. Box 7, Nablus 99900800, Palestine., Iakoubov R; Department of Internal Medicine II, University Hospital Rechts der Isar, School of Medicine, Technical University, 81675 Munich, Germany., Vehreschild JJ; Medical Department II, University Hospital of Frankfurt, 60590 Frankfurt, Germany., Rios R; Institute of Computing, Federal University of Bahia, Salvador 40110060, Brazil., Nogueira T; Institute of Computing, Federal University of Bahia, Salvador 40110060, Brazil., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany., Stecher M; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.; German Center for Infection Research (DZIF), Partner-Site Bonn-Cologne, 50937 Cologne, Germany., Mori H; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Lanznaster J; Klinikum Passau, 94032 Passau, Germany., Adachi E; IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan., Jakob C; Department I for Internal Medicine, University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.; German Center for Infection Research (DZIF), Partner-Site Bonn-Cologne, 50937 Cologne, Germany., Tabe Y; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Ruethrich M; Universitaetsklinikum, 07747 Jena, Germany., Borgmann S; Ingolstadt Hospital, 85049 Ingolstadt, Germany., Naito T; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Wille K; Johannes Wesling Klinikum Minden, Ruhr-Universitaet, 44801 Bochum, Germany., Valenti S; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Hower M; Klinikum Dortmund gGmbH, Hospital of University Witten/Herdecke, 44137 Dortmund, Germany., Hattori N; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Rieg S; Universitaetsklinikum, 79106 Freiburg, Germany., Nagaoka T; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Jensen BE; Universitaetsklinikum, 40225 Duesseldorf, Germany., Yotsuyanagi H; IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan., Hertenstein B; Klinikum Bremen-Mitte, 28205 Bremen, Germany., Ogawa H; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Wyen C; Praxis am Ebertplatz Koeln, 50668 Köln, Germany., Kominami E; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Roemmele C; Internal Medicine III-Gastroenterology and Infectious Diseases, University Hospital of Augsburg, 86156 Augsburg, Germany., Takahashi S; IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan., Rupp J; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Luebeck, 23538 Luebeck, Germany., Takahashi K; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., Hanses F; Emergency Department and Department for Infectious Diseases and Infection Control, University Hospital Regensburg, 93053 Regensburg, Germany., Hattori K; School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan., On Behalf Of The Leoss Study Group
Publikováno v:
Biomedicines [Biomedicines] 2022 Oct 12; Vol. 10 (10). Date of Electronic Publication: 2022 Oct 12.